Skip to main content
. 2020 Jan 27;22(4):658–668. doi: 10.1111/dom.13944

Figure 1.

Figure 1

Change in mean HbA1c over 26 weeks by previous (A, B) sulphonylurea (SU) and (C, D) dipeptidyl peptidase‐4 inhibitor (DPP4i) use. Data are mean (SEM) and based on the full analysis set. ADA, American Diabetes Association; Degludec, insulin degludec; EASD, European Association for the Study of Diabetes; IDegLira, insulin degludec/liraglutide; IGlar U100, insulin glargine U100; SEM, standard error of the mean